Holding(s) in Company

RNS Number : 3294L

Venn Life Sciences Holdings PLC

08 January 2016

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii				Venn Life Sciences Holdings Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights					Yes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached					No
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments					No
An event changing the breakdown of voting rights					Yes
Other (please specify):					No
3. Full name of person(s) subject to the notification obligation: iii		Livingbridge VC LLP
4. Full name of shareholder(s)  (if different from 3.):iv		Baronsmead VCT plc    4.89% Baronsmead VCT 2 plc 4.89% Baronsmead VCT 3 plc 4.89% Baronsmead VCT 4 plc 4.89% Baronsmead VCT 5 plc 2.17%
5. Date of the transaction and date on which the threshold is crossed or reached: v		12/10/2015
6. Date on which issuer notified:		22/10/2015
7. Threshold(s) that is/are crossed or reached: vi, vii		14%, 15%, 16%, 17%, 18%, 19%, 20% & 21%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Common Stock GBP GB00B9275X97

5,263,157

13.42%

13,081,337

21.72%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

Nil

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

13,081,337

21.72%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

Livingbridge VC LLP Baronsmead VCT plc    4.89% Baronsmead VCT 2 plc 4.89% Baronsmead VCT 3 plc 4.89% Baronsmead VCT 4 plc 4.89% Baronsmead VCT 5 plc 2.17% Registered in the name of Chase Nominees Ltd

Proxy Voting:

10. Name of the proxy holder:

Livingbridge VC LLP

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

14. Contact name:

Karen Huxley

15. Contact telephone number:

020 7506 5643

Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in share
A: Identity of the persons or legal entity subject to the notification obligation
Full name (including legal form of legal entities)	Venn Life Sciences Holdings Plc
Contact address (registered office for legal entities)	4 Lombard Street London EC3V 9H2
Phone number & email	[e-mail] Tel: [phone]
Other useful information (at least legal representative for legal persons)
B: Identity of the notifier, if applicable
Full name	Karen Huxley, Livingbridge VC LLP
Contact address	100 Wood Street, London, EC2V 7AN
Phone number & email	020 7506 5643 [e-mail]
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)
C: Additional information
For notes on how to complete form TR-1 please see the FSA website.

 

END

 

 

HOLEADFPESXKEFF